Page last updated: 2024-10-29

indomethacin and Cancer of Pharynx

indomethacin has been researched along with Cancer of Pharynx in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Djalilian, HR1
Caicedo, E1
Lessan, K1
Grami, V1
Le, CT1
Spellman, SR1
Pambuccian, S1
Hall, WA1
Low, WC1
Ondrey, FG1

Other Studies

1 other study available for indomethacin and Cancer of Pharynx

ArticleYear
Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8

    Topics: Animals; Cancer Vaccines; Carcinoma, Squamous Cell; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Dr

2007